What is the recommended management for an infant with gastro‑oesophageal reflux disease presenting with projectile vomiting, poor weight gain, irritability, and chronic cough, including non‑pharmacologic measures, medication options, and criteria for specialist referral?

Management of GERD in Infants with Projectile Vomiting, Poor Weight Gain, Irritability, and Chronic Cough

Begin with a 2–4 week trial of extensively hydrolyzed protein or amino acid–based formula (or maternal elimination diet if breastfeeding), combined with feeding modifications, before considering any diagnostic testing or medications. 1

Immediate Red Flag Assessment

The presentation of projectile vomiting with poor weight gain requires urgent evaluation to exclude surgical emergencies:

• Obtain an upper GI series immediately to rule out pyloric stenosis, malrotation, or other anatomic abnormalities when vomiting is consistently forceful or projectile. 2
• Check for bilious vomiting, gastrointestinal bleeding, abdominal distension, fever, or lethargy—any of these mandate laboratory work-up and imaging before treating as GERD. 1
• Poor weight gain is a crucial warning sign that distinguishes pathologic GERD from physiologic reflux and alters management from reassurance to active intervention. 2

First-Line Non-Pharmacologic Management

Feeding Modifications (Mandatory Initial Step)

Cow's milk protein allergy mimics or worsens GERD in 42–58% of infants, making dietary modification the cornerstone of initial therapy:

• For formula-fed infants: Switch to extensively hydrolyzed protein or amino acid–based formula for 2–4 weeks. 2, 1
• For breastfed infants: Mother eliminates cow's milk and eggs from her diet for 2–4 weeks; do not discontinue breastfeeding. 2, 1
• Thicken feeds with up to 1 tablespoon of dry rice cereal per ounce of formula if symptoms persist after formula change. 2, 1
• Reduce feeding volumes while increasing frequency to prevent gastric distension and overfeeding. 2
• Monitor weight gain closely as the primary outcome measure; thickened feeds increase caloric density and may cause excessive weight gain. 1

Positioning Strategies

• Keep infant upright for 10–20 minutes after each feeding to promote burping and decrease reflux episodes. 1
• Prone or left-side positioning may reduce reflux but only when infant is awake and under direct supervision due to SIDS risk. 2
• Avoid seated positioning (car seats, bouncy chairs) immediately after feeds, as this increases intra-abdominal pressure. 2

Expected Timeline

• Approximately 24% of infants achieve complete symptom resolution after 2 weeks of hydrolyzed formula combined with thickening and feeding adjustments. 2
• If no improvement occurs after 2–4 weeks of conservative measures, proceed to specialist referral. 1

When to Refer to Pediatric Gastroenterology

Refer immediately if:

• No improvement after 2–4 weeks of formula modification and feeding adjustments. 1
• Presence of warning signs: bilious vomiting, gastrointestinal bleeding, failure to thrive, hematemesis, or recurrent pneumonia. 2, 1
• Severe symptoms suggesting complications: feeding refusal, severe irritability, or respiratory manifestations (choking, coughing during feeds). 2, 1

Diagnostic Testing (Only After Conservative Measures Fail)

Upper Endoscopy with Biopsy (Gold Standard)

• Indicated when conservative measures fail after 2–4 weeks or when warning signs are present. 2, 1
• Approximately 25% of infants <1 year have histologic esophageal inflammation detectable only by biopsy. 2
• Essential to exclude eosinophilic esophagitis, which mimics GERD but requires different therapy. 2, 1
• Biopsy confirms erosive esophagitis and guides decisions about acid-suppressive therapy. 2, 1

Tests to Avoid

• Barium upper GI series has high false-positive rates because physiologic reflux during the brief study is common; use only to identify structural abnormalities. 1
• Standard esophageal pH monitoring misses ~85% of reflux episodes in infants who predominantly experience non-acid reflux due to frequent feeds. 1
• Combined pH-multiple intraluminal impedance (MII-pH) should be performed only after endoscopy when detailed assessment of both acid and non-acid reflux is required. 1

Pharmacologic Therapy (Reserved for Biopsy-Proven Esophagitis)

Acid-Suppressive Agents

Proton pump inhibitors (PPIs) or H2-receptor antagonists should be reserved exclusively for infants with endoscopically confirmed erosive esophagitis:

• Do not use PPIs as an empiric diagnostic test; lack of response does not rule out GERD, and response does not confirm diagnosis. 1
• Acid-suppressive medications increase risks of community-acquired pneumonia, gastroenteritis, candidemia, and necrotizing enterocolitis in preterm infants. 2, 1
• H2 antagonists cause tachyphylaxis within 6 weeks and may increase risk of liver disease and gynecomastia. 2
• PPIs are most effective when dosed 30 minutes before meals, and metabolism differs in infants compared to adults. 2

Prokinetic Agents (Not Recommended)

• Routine use of prokinetic agents (metoclopramide, cisapride, bethanechol, erythromycin) is not recommended because evidence of benefit is insufficient. 2, 1
• Adverse effects occur in 11–34% of patients, including drowsiness, restlessness, and extrapyramidal reactions. 1
• Metoclopramide carries a black-box warning for serious adverse effects. 1

Surgical Considerations

Fundoplication Indications

Fundoplication is reserved for carefully selected infants who:

• Have failed pharmacologic treatment with documented erosive esophagitis. 2
• Are at severe risk of aspiration of gastric contents. 2, 1

Pre-Surgical Requirements

• If PPI therapy is ineffective, reassess the GERD diagnosis before surgery because fundoplication will not improve cyclic vomiting, rumination, gastroparesis, or eosinophilic esophagitis. 2, 1
• Counsel families thoroughly about potential complications, including symptom recurrence and the fact that direct aspiration of oral contents is not corrected by the procedure. 2, 1
• Both fundoplication and total esophagogastric dissociation are associated with significant morbidity. 2

Critical Pitfalls to Avoid

• Do not over-diagnose or overtreat reflux; most "happy spitters" with uncomplicated reflux need only reassurance, not formula changes or medications. 2, 3
• Avoid prescribing acid-suppressive agents prematurely in infants <1 year, as they are ineffective for symptom relief and carry notable risks. 2, 1
• Do not rely solely on symptoms to diagnose GERD in infants, as symptoms are unreliable and overlap with normal infant behavior. 1
• Never assume all infants with reflux at 4 months (peak incidence) have GERD requiring treatment; the vast majority need only parental reassurance about the benign, self-resolving nature of physiologic reflux. 3
• Symptoms attributed to GERD are non-specific and overlap with age-appropriate behaviors; irritability may be due to cow's milk protein allergy, neurologic disorders, constipation, or infection. 4

Natural History and Parental Counseling

• Infantile reflux peaks at 4 months of age, affecting ~50% of infants, then declines to 5–10% by 12 months. 3
• By 12 months, 90–95% of cases resolve spontaneously without intervention. 3
• Provide anticipatory guidance that physiologic reflux is effortless, painless, and does not affect growth in "happy spitters." 2, 3